Citation·page:coalition-for-epidemic-preparedness-innovations:fn17

Coalition for Epidemic Preparedness Innovations - Footnote 17

Verdictpartial90%

1 check · 4/3/2026

The claim mentions SARS-CoV-2 variant-specific vaccines, while the source mentions vaccines that protect against multiple SARS-CoV-2 variants and other coronaviruses. The claim mentions linking surveillance systems to vaccine development decisions, which is not explicitly stated in the source.

Our claim

entire record

No record data available.

Source evidence

1 src · 1 check

www.glopid-r.org/articles-newsletter/cepis-3-5bn-plan-to-tackle-the-outbreaks-of-today-and-tomorrow/resource

partial90%Haiku 4.5 · 4/3/2026

NoteThe claim mentions SARS-CoV-2 variant-specific vaccines, while the source mentions vaccines that protect against multiple SARS-CoV-2 variants and other coronaviruses. The claim mentions linking surveillance systems to vaccine development decisions, which is not explicitly stated in the source.

Case № page:coalition-for-epidemic-preparedness-innovations:fn17Filed 4/3/2026Confidence 90%